Michael Shear

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

W. Krauwinkel, M. Michel, A. Quartel, 2005 .

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.

A. Burden, Patrick Baum, H. Turki, 2019, The New England journal of medicine.

Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies

T. Krahnke, J. Podhorná, Michael Shear, 2016, Alzheimer's Research & Therapy.

Comparison of Vascular α1-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

W. Krauwinkel, M. Michel, A. Quartel, 2005 .

Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies

T. Krahnke, J. Podhorná, Michael Shear, 2016, Alzheimer's Research & Therapy.